We are live on ! Find out more
CA

Capital Advantage Portfolio holdings

AUM $820M
1-Year Est. Return 20.6%
This Fund
S&P 500
This Quarter Est. Return
-5.68%
1 Year Est. Return
+20.6%
3 Year Est. Return
+44.41%
5 Year Est. Return
+43.97%
10 Year Est. Return
AUM
$257M
AUM Growth
+$145K
Cap. Flow
+$15.7M
Cap. Flow %
6.1%
Top 10 Hldgs %
67.59%
Holding
77
New
6
Increased
48
Reduced
15
Closed
5
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVX icon
26
Chevron
CVX
$396B
$1.54M 0.6%
19,588
+2,527
+15% +$213K
SCHX icon
27
Schwab US Large- Cap ETF
SCHX
$74.3B
$1.43M 0.56%
187,236
+131,136
+234% +$1.06M
SCHD icon
28
Schwab US Dividend Equity ETF
SCHD
$111B
$1.33M 0.52%
111,048
+42,867
+63% +$535K
SCHO icon
29
Schwab Short-Term US Treasury ETF
SCHO
$13B
$1.27M 0.49%
49,878
-51,780
-51% -$1.31M
GE icon
30
GE Aerospace
GE
$354B
$1.24M 0.48%
10,295
+1,202
+13% +$147K
SCHM icon
31
Schwab US Mid-Cap ETF
SCHM
$14.9B
$1.18M 0.46%
91,248
+22,692
+33% +$315K
SCHA icon
32
Schwab U.S Small- Cap ETF
SCHA
$22.7B
$1.14M 0.44%
89,528
+41,664
+87% +$574K
T icon
33
AT&T
T
$177B
$1.13M 0.44%
46,002
+16,996
+59% +$433K
NOC icon
34
Northrop Grumman
NOC
$77.6B
$1.07M 0.42%
6,440
VIG icon
35
Vanguard Dividend Appreciation ETF
VIG
$113B
$1.01M 0.39%
13,718
-590
-4% -$45.7K
JNJ icon
36
Johnson & Johnson
JNJ
$639B
$866K 0.34%
9,276
+840
+10% +$81.3K
MSFT icon
37
Microsoft
MSFT
$3.84T
$859K 0.33%
19,411
+686
+4% +$30.8K
SCHE icon
38
Schwab Emerging Markets Equity ETF
SCHE
$12.9B
$858K 0.33%
42,412
+25,642
+153% +$561K
RTX icon
39
RTX Corp
RTX
$285B
$734K 0.29%
13,101
-94
-0.7% -$5.79K
PG icon
40
Procter & Gamble
PG
$333B
$608K 0.24%
8,451
+171
+2% +$12.8K
VPL icon
41
Vanguard FTSE Pacific ETF
VPL
$8.54B
$596K 0.23%
11,109
+7,140
+180% +$413K
MCK icon
42
McKesson
MCK
$104B
$584K 0.23%
3,157
+107
+4% +$22.7K
CSCO icon
43
Cisco
CSCO
$433B
$554K 0.22%
21,094
+2,536
+14% +$68.5K
AMZN icon
44
Amazon
AMZN
$2.86T
$484K 0.19%
18,900
-40
-0.2% -$1.01K
MRK icon
45
Merck
MRK
$364B
$475K 0.19%
10,077
+4,143
+70% +$220K
PFE icon
46
Pfizer
PFE
$159B
$474K 0.18%
15,909
+1,242
+8% +$39.8K
IBM icon
47
IBM
IBM
$222B
$466K 0.18%
3,365
+1,074
+47% +$159K
META icon
48
Meta Platforms (Facebook)
META
$1.46T
$466K 0.18%
5,184
-6,700
-56% -$615K
MINT icon
49
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.4B
$440K 0.17%
4,367
-2,617
-37% -$265K
VZ icon
50
Verizon
VZ
$208B
$433K 0.17%
9,944
+3,432
+53% +$158K

Similar funds

Capital Advantage's Q3 2015 Portfolio in Review

As of Q3 2015, Capital Advantage held 77 positions worth $257M, up 0.06% from $257M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Capital Advantage deployed $15.7M of net new capital in Q3 2015, opening 6 new positions and adding to 48 existing holdings. Its largest new stake was Vanguard Total International Stock ETF: 93,338 shares worth $4.14M.

By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, up from 91% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Guggenheim BulletShares 2016 Corporate Bond ETF, an estimated $1.92M trimmed.

  • Capital Advantage's largest Q3 2015 buy was Vanguard Total International Stock ETF: 93,338 shares worth $4.14M.
  • Capital Advantage added most to iShares Core MSCI EAFE ETF in Q3 2015, an estimated $2.24M increase.
  • Capital Advantage's biggest Q3 2015 reduction was Guggenheim BulletShares 2016 Corporate Bond ETF, cutting an estimated $1.92M.
  • Capital Advantage fully exited Abbott in Q3 2015, selling an estimated $230K.
  • Capital Advantage's ten largest holdings make up 68% of its $257M portfolio in Q3 2015.
  • Capital Advantage opened 6 new positions and closed 5 in Q3 2015.
  • Capital Advantage's portfolio value rose 0.06% quarter-over-quarter to $257M.

Based on Capital Advantage's 13F filing for Q3 2015, filed 23 Oct 2015.